CI vs KRRO · P/E 2.4, rev $274.90B vs rev $2.3M
Cigna Corp (CI) versus Korro Bio, Inc. (KRRO) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Korro Bio, Inc. (KRRO) is a biotechnology company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported KRRO revenue for 2024-12-31 was $2.3M. Net income was -$83.6M. KRRO currently screens at market cap $159.8M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. KRRO currently screens at market cap $159.8M.
Not investment advice. Open the CI and KRRO stock pages for the full models.
Not investment advice.